Procera Networks launched Virtualized PacketLogic solutions based on the European Telecommunications Standards Institute (ETSI) Network Functions Virtualization (NFV) initiative.
The company’s Virtualized PacketLogic solution for intelligent policy enforcement will be in a carrier-class, virtualized “appliance” package running on commodity hardware. The virtualized version will offer the same software functionality as the current hardware platform. Any hardware solution that can run standard-based virtualization software can be deployed with the PacketLogic solution modules (PSM, PRE, and PIC), including deployments that run all of the modules on a single hardware platform.
Procera said NFV enables easier performance and scalability upgrades by simply adding more CPU and memory to the virtual machine. The Virtual PacketLogic solutions can be used for any portion of the lifecycle of a Policy Enforcement deployment from the initial functional evaluation, trial deployment, service rollout, bandwidth expansion, or geographic expansion, lowering the cost of acquisition of IPE technology as well as the operational cost.
“The main promise of NFV is to benefit from commodity pricing of IT hardware, reduced power consumption and moving to a much faster service delivery method based on downloading software appliances as opposed to installing new hardware appliances,” said Paul Veitch, chief network strategist at British Telecom.
“Virtualization is a natural evolution of the PacketLogic architecture,” said Alexander Havang, chief technology officer for Procera. “Procera has always maintained hardware independence, and has delivered the highest performing solutions available on the market using off-the-shelf hardware technology. We have used virtualization extensively internally, and our customers are asking to deploy this in their networks today. Speed to market with new services and the ability to deliver targeted niche services also becomes a much simpler and more rapid process.”
Procera’s Virtual PacketLogic solutions will be available for trial in the third quarter of 2013, and are expected to be generally available by the end of 2013.
